IDO1 and neoplasm: Previous studies have demonstrated the immunomodulatory effects of IDO1 on multiple types of immune cells, including tumor-associated DCs, regulatory T cells (Tregs), myeloid-derived suppressor cells (MDSCs), NK cells, and TAMs.